Search research articles
Contact Us
Filters
Showing results (11-20 of 832) with videos related to
Page
of 84
Sort By:
Intestinal Research
|
November 6, 2025
Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey"
Julajak Limsrivilai, Wai Keung Leung
Intestinal Research
|
October 20, 2023
Pyogenic granuloma after embolization of a duodenal arteriovenous malformation in a patient with bleeding of obscure origin
Leticia Rosevics, Bruna Streppel Fossati, Elisandre Caroline Dos Santos Cerutti, et al.
Intestinal Research
|
July 30, 2019
Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
Hyuk Yoon
Intestinal Research
|
May 14, 2016
Changing epidemiological trends of inflammatory bowel disease in Asia
Wee Khoon Ng, Sunny H Wong, Siew C Ng
Intestinal Research
|
May 14, 2016
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
Kai-Chun Wu, Zhi Hua Ran, Xiang Gao, et al.
Intestinal Research
|
May 14, 2016
Do we need colonoscopy verification in patients with fundic gland polyp?
Hee Sook Lee, Younjeong Choi, Ja Young Jung, et al.
Intestinal Research
|
May 14, 2016
Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis
Jatinderpal Singh, Amarender S Puri, Sanjeev Sachdeva, et al.
Intestinal Research
|
May 14, 2016
Wernicke's encephalopathy after total parenteral nutrition in patients with Crohn's disease
In Seub Shin, Hyeri Seok, Yeong Hee Eun, et al.
Intestinal Research
|
February 18, 2016
The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing
Takuya Yoshino, Kohei Yamakawa, Satoshi Nishimura, et al.
Intestinal Research
|
February 18, 2016
Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study
Yasuo Suzuki, Mitsuo Iida, Hiroaki Ito, et al.
Page
of 84
Search research articles
Search
Showing results (11-20 of 832) with videos related to
Sort By:
Page
of 84
Intestinal Research
|
November 6, 2025
Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey"
Julajak Limsrivilai, Wai Keung Leung
Intestinal Research
|
October 20, 2023
Pyogenic granuloma after embolization of a duodenal arteriovenous malformation in a patient with bleeding of obscure origin
Leticia Rosevics, Bruna Streppel Fossati, Elisandre Caroline Dos Santos Cerutti, et al.
Intestinal Research
|
July 30, 2019
Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
Hyuk Yoon
Intestinal Research
|
May 14, 2016
Changing epidemiological trends of inflammatory bowel disease in Asia
Wee Khoon Ng, Sunny H Wong, Siew C Ng
Intestinal Research
|
May 14, 2016
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
Kai-Chun Wu, Zhi Hua Ran, Xiang Gao, et al.
Intestinal Research
|
May 14, 2016
Do we need colonoscopy verification in patients with fundic gland polyp?
Hee Sook Lee, Younjeong Choi, Ja Young Jung, et al.
Intestinal Research
|
May 14, 2016
Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis
Jatinderpal Singh, Amarender S Puri, Sanjeev Sachdeva, et al.
Intestinal Research
|
May 14, 2016
Wernicke's encephalopathy after total parenteral nutrition in patients with Crohn's disease
In Seub Shin, Hyeri Seok, Yeong Hee Eun, et al.
Intestinal Research
|
February 18, 2016
The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing
Takuya Yoshino, Kohei Yamakawa, Satoshi Nishimura, et al.
Intestinal Research
|
February 18, 2016
Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study
Yasuo Suzuki, Mitsuo Iida, Hiroaki Ito, et al.
Page
of 84